Total Payments
$998.37
2024 Payments
$69.52
Companies
6
Transactions
50
Medicare Patients
720
Medicare Billing
$366,239
Payment Breakdown by Category
Food & Beverage$998.37 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $998.37 | 50 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Allergan, Inc. | $416.74 | 17 | $0 (2020) |
| ABBVIE INC. | $334.79 | 21 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $125.95 | 4 | $0 (2024) |
| ITI, Inc. | $57.33 | 3 | $0 (2022) |
| Lundbeck LLC | $37.06 | 3 | $0 (2022) |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $26.50 | 2 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $69.52 | 5 | Otsuka America Pharmaceutical, Inc. ($28.70) |
| 2023 | $265.28 | 17 | AbbVie Inc. ($250.18) |
| 2022 | $61.36 | 4 | ITI, Inc. ($33.81) |
| 2021 | $80.72 | 4 | AbbVie Inc. ($57.20) |
| 2020 | $26.96 | 2 | Allergan, Inc. ($26.96) |
| 2019 | $177.62 | 8 | Allergan Inc. ($165.90) |
| 2018 | $82.15 | 1 | Otsuka America Pharmaceutical, Inc. ($82.15) |
| 2017 | $234.76 | 9 | Allergan Inc. ($223.88) |
All Payment Transactions
50 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 06/27/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $15.55 | General |
| Category: PSYCHIATRY | ||||||
| 05/20/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $13.12 | General |
| Category: PSYCHIATRY | ||||||
| 03/13/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $13.38 | General |
| Category: PSYCHIATRY | ||||||
| 03/07/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $13.15 | General |
| Category: PSYCHIATRY | ||||||
| 02/28/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $14.32 | General |
| Category: NEUROSCIENCE | ||||||
| 11/29/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $3.15 | General |
| Category: NEUROSCIENCE | ||||||
| 11/29/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $3.00 | General |
| Category: NEUROSCIENCE | ||||||
| 11/09/2023 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $15.10 | General |
| Category: PSYCHIATRY | ||||||
| 10/24/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $25.61 | General |
| Category: NEUROSCIENCE | ||||||
| 09/28/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $14.61 | General |
| Category: NEUROSCIENCE | ||||||
| 09/28/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $4.62 | General |
| Category: NEUROSCIENCE | ||||||
| 07/18/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $20.00 | General |
| Category: NEUROSCIENCE | ||||||
| 06/05/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $11.28 | General |
| Category: NEUROSCIENCE | ||||||
| 04/26/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $6.59 | General |
| Category: NEUROSCIENCE | ||||||
| 04/26/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $4.23 | General |
| Category: NEUROSCIENCE | ||||||
| 03/08/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $11.94 | General |
| Category: NEUROSCIENCE | ||||||
| 03/08/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $10.52 | General |
| Category: NEUROSCIENCE | ||||||
| 03/08/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $3.98 | General |
| Category: NEUROSCIENCE | ||||||
| 02/22/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $20.87 | General |
| Category: NEUROSCIENCE | ||||||
| 01/19/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $98.71 | General |
| Category: NEUROSCIENCE | ||||||
| 01/05/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $6.91 | General |
| Category: NEUROSCIENCE | ||||||
| 01/05/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $4.16 | General |
| Category: NEUROSCIENCE | ||||||
| 09/13/2022 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $14.46 | General |
| Category: PSYCHIATRY | ||||||
| 07/28/2022 | ITI, Inc. | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $13.42 | General |
| Category: PSYCHIATRY | ||||||
| 02/09/2022 | ITI, Inc. | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $20.39 | General |
| Category: PSYCHIATRY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 162 | 1,065 | $138,648 | $91,861 |
| 2022 | 5 | 176 | 1,128 | $150,500 | $99,076 |
| 2021 | 5 | 182 | 1,157 | $152,934 | $103,783 |
| 2020 | 4 | 200 | 1,351 | $113,236 | $71,519 |
Total Patients
720
Total Services
4,701
Medicare Billing
$366,239
Procedure Codes
18
All Medicare Procedures & Services
18 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 45 | 386 | $71,787 | $47,881 | 66.7% |
| 90836 | Psychotherapy with evaluation and management visit, 45 minutes | Office | 2023 | 48 | 423 | $39,152 | $26,427 | 67.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 36 | 147 | $19,691 | $12,325 | 62.6% |
| 90833 | Psychotherapy with evaluation and management visit, 30 minutes | Office | 2023 | 33 | 109 | $8,017 | $5,228 | 65.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 49 | 384 | $73,654 | $48,530 | 65.9% |
| 90836 | Psychotherapy with evaluation and management visit, 45 minutes | Office | 2022 | 53 | 415 | $39,715 | $26,580 | 66.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 34 | 175 | $23,822 | $15,314 | 64.3% |
| 90833 | Psychotherapy with evaluation and management visit, 30 minutes | Office | 2022 | 29 | 143 | $10,958 | $7,142 | 65.2% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Office | 2022 | 11 | 11 | $2,351 | $1,510 | 64.2% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 47 | 392 | $75,121 | $51,760 | 68.9% |
| 90836 | Psychotherapy with evaluation and management visit, 45 minutes | Office | 2021 | 50 | 456 | $43,517 | $30,004 | 68.9% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 37 | 161 | $22,609 | $14,688 | 65.0% |
| 90833 | Psychotherapy performed with evaluation and management visit, 30 minutes | Office | 2021 | 32 | 125 | $9,440 | $6,326 | 67.0% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 16 | 23 | $2,248 | $1,005 | 44.7% |
| 90836 | Psychotherapy, 45 minutes | Office | 2020 | 59 | 515 | $53,935 | $33,353 | 61.8% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 56 | 469 | $37,060 | $24,377 | 65.8% |
| 90833 | Psychotherapy, 30 minutes | Office | 2020 | 42 | 160 | $12,366 | $7,711 | 62.4% |
| 99212 | Established patient office or other outpatient visit, typically 10 minutes | Office | 2020 | 43 | 207 | $9,874 | $6,078 | 61.6% |
About Dr. Gregory Dray, MD
Dr. Gregory Dray, MD is a Specialist healthcare provider based in Asheville, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/20/2006. The National Provider Identifier (NPI) number assigned to this provider is 1710942834.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Gregory Dray, MD has received a total of $998.37 in payments from pharmaceutical and medical device companies, with $69.52 received in 2024. These payments were reported across 50 transactions from 6 companies. The most common payment nature is "Food and Beverage" ($998.37).
As a Medicare-enrolled provider, Dray has provided services to 720 Medicare beneficiaries, totaling 4,701 services with total Medicare billing of $366,239. Data is available for 4 years (2020–2023), covering 18 distinct procedure/service records.
Ad
Practice Information
- Specialty Specialist
- Other Specialties Psychiatry, Geriatric Psychiatry
- Location Asheville, NC
- Active Since 04/20/2006
- Last Updated 09/25/2015
- Taxonomy Code 174400000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1710942834
Products in Payments
- VRAYLAR (Drug) $739.21
- REXULTI (Drug) $140.41
- CAPLYTA (Drug) $83.83
- UBRELVY (Drug) $12.32
- BRINTELLIX (Drug) $11.72
- TRINTELLIX (Drug) $10.88
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Specialist Doctors in Asheville
Charles Buzzanell, M.d, M.D
Specialist — Payments: $7,870
Specialist $7,870
Peter Jaber, Md, MD
Specialist — Payments: $4,838
Specialist $4,838
Mrs. Brenda Draper, M.d, M.D
Specialist — Payments: $4,640
Specialist $4,640
Daniel Smith, Md, MD
Specialist — Payments: $3,377
Specialist $3,377
Virginia Waymouth, Agacnp-Bc, AGACNP-BC
Specialist — Payments: $1,996
Specialist $1,996
Dr. Marilee Mcginness, M.d, M.D
Specialist — Payments: $1,462
Specialist $1,462